Medsharing to moderate the workshop ‘eHealth and regulations’ and to exhibit at 6th Clinical Reach Day in Paris, France
January, 26th at Méridien Porte Maillot in Paris, France
Come and visit us!
(Conference in French)
The 3sites study, sponsored by French Caen University Hospital, and for which Medsharing’s EOL software has been used, has been published in the New England Journal of Medicine dated 24 September 2015
Intravascular Complications of Central Venous Catheterization by Insertion Site http://www.nejm.org/doi/full/10.1056/NEJMoa1500964
Medsharing, the eCRF leader, to exhibit at Data Management Biomedical Conference, Paris, Nov 10th 2015.
Topics are Central Monitoring, Clinical trials outsourcing and connected devices.
To know more about Medsharing’s solutions for clinical trials, registries or patients' quality of life questionnaires, please contact us at +33 1 48 75 39 14 or email@example.com or visit http://www.ecrf-medsharing.com/
Medsharing SARL, the provider of SaaS eCRF and randomisation software EOL© for interventional and observational medical research, announces the signature of a contract with the Osteoporosis Medial Center (OMC) in Beverly Hills, California, USA (www.omcresearch.org).
OMC will be using EOL© for a multicentric Drug Holiday Study in the US.
« We chose Medsharing for its reactivity and support level. Medsharing has provided excellent support and rapid turnaround in the development phase of our eCRF so far. »
– Dr Stuart L. Silverman, MD FACP FACR, Clinical Professor of Medicine, UCLA School of Medicine and Medical Director, OMC Clinical Research Center.
To know more about Medsharing’s solutions, please contact us at +33 1 48 75 39 14+33 1 48 75 39 14 or firstname.lastname@example.org
AFCP - French Foot Association Surgery
"We needed a reliable solution, with an exellent quality-price ratio, reachable from allover the French territory. Medsharing fully satisfied us by its reactivity, its adaptability and its software ergonomy, usable with a very light training.
EOL software is so simple to use, that we even use it directly in the operating room".
Dr Jean-Luc Besse, M.D., Ph.D - Surgeon at Hospices Civils de Lyon and Past-Président, AFCP, member of the EFAS (European Foot and Ankle Society) Executive Committee (2014).
STENTYS successfully collects real-world data for post marketing surveillance in eight European countries
“Medsharing EOL software is easy to work with; for example we can easily extract data and create reports ourselves. Medsharing have always been very responsive to our requests and the eCRF has excellent response times. The screen layout and the inclusion of graphics in the CRF pages facilitate patient data entry for site personnel.”
Click to read the success story ...
On the 2nd of April, we launch our 100th one study.
Thank to the Clinical Investigation Center of Grenoble!
RANDOMIZER for CLINICAL TRIAL, which includes the possibility of exporting directly to Excel your patients lists.
You can download this apps via the appstore keywords : medsharing, randomizer, ...) or you can visit our iPhone/iPad randomization page.
This application, is simple, intuitive and practical, can be used with every type of studies. It allows to create as many study as you want and include an unlimited number of patients.
Do you need informations about eCRF improvment? Go to Designing your study
EOL software is 100% compatible with all new mobile devices such as ipad and iphone but also other smartphones. Our light and compatible with all browser technology makes our solution very easy to use with tablets and smartphones.
Data entry and randomization are directly available on your mobile device anywhere or via your internet connexion.
Don't hesitate to send your feedback on this first randomizer application. A non restricted version will be available soon.
EOL New brochure available!
March 2016 : EOL the new brochure is available!
Medsharing in figures
78,000 patients since 2003 for over 130 studies.
26 Registries / Observatories.
61 Clinical Trials
31 Randomizations (without eCRF)
47 Drug Studies
28 DM Studies
66 Ongoing studies.
+33 (0)1 48 75 39 14